Amarin Corp ADR
(NQ:
AMRN
)
0.5828
+0.0028 (+0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amarin Corp ADR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Amarin Corporation plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
October 26, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
LAWSUITS FILED AGAINST SAM, HYZN and AMRN - Jakubowitz Law Pursues Shareholders Claims
October 26, 2021
NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...
From
Jakubowitz Law
Via
AccessWire
Topics
Fraud
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, BMRN and AMRN
October 26, 2021
NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...
From
The Klein Law Firm
Via
AccessWire
Topics
Fraud
Intellectual Property
Exposures
Intellectual Property
Legal
Product Safety
Analyzing Amarin Corp's Unusual Options Activity
August 11, 2021
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...
Via
Benzinga
Analyzing Amarin Corp's Unusual Options Activity
August 05, 2021
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
October 26, 2021
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ALERT: HEPS BMRN AMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
October 26, 2021
NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...
From
The Law Offices of Vincent Wong
Via
AccessWire
Topics
Fraud
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
AMRN ALERT: Amarin Corporation plc Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 25, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
CORRECTING and REPLACING AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc
October 25, 2021
From
The Schall Law Firm
Via
Business Wire
AMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Amarin Corporation PLC and Encourages Investors to Contact the Firm
October 25, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc
October 24, 2021
From
The Schall Law Firm
Via
Business Wire
Cramer Shares His Thoughts On Dynavax, Nucor And Amarin
September 24, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories. Cramer said you are...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:
Via
Benzinga
Amarin Stock Moves Higher As Vascepa Cuts Risk Of Heart Attacks
August 23, 2021
Amarin Corporation plc (NASDAQ: AMRN) announced additional data on Vascepa/Vazkepa (icosapent ethyl) in patients with prior heart attack, known as myocardial...
Via
Benzinga
77 Biggest Movers From Yesterday
August 13, 2021
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...
Via
Benzinga
Why Amarin Is Soaring Today
August 05, 2021
The pharmaceuticals company is showing surprising resilience in the face of competition.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
Amarin (AMRN) Q2 2021 Earnings Call Transcript
August 05, 2021
AMRN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Amarin Q2 Earnings
August 05, 2021
Shares of Amarin Corp (NASDAQ:AMRN) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the...
Via
Benzinga
Understanding Amarin Corp's Unusual Options Activity
July 19, 2021
Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22. Sentiment: BEARISH Option...
Via
Benzinga
Why Amarin Fell Again Today
June 22, 2021
Another Vascepa generic is launched in the U.S.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
48 Biggest Movers From Yesterday
June 22, 2021
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide
June 21, 2021
Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
31 Stocks Moving In Monday's Mid-Day Session
June 21, 2021
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...
Via
Benzinga
Why Amarin Stock Is Sinking Today
June 21, 2021
The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
Understanding Amarin Corp's Unusual Options Activity
June 09, 2021
Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type...
Via
Benzinga
Market Briefing For Tuesday, Jun. 8
June 08, 2021
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first.
Via
Talk Markets
Why Amarin Trounced the Market on Tuesday
May 18, 2021
Investors reacted positively to a company presentation at an industry convention.
Via
The Motley Fool
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.